1 results match your criteria: "Utrecht Institute for Pharmaceutical Sciences (UIPS) Utrecht University Utrecht The Netherlands.[Affiliation]"
The efficacy of a combination of naproxen and fexofenadine (SJP - 002) to inhibit the symptoms that are associated with viral upper respiratory tract infection: Four case reports of individuals with common cold.
Clin Case Rep
July 2023
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS) Utrecht University Utrecht The Netherlands.
Key Clinical Message: There is no effective treatment that reduces both the severity and duration of a common cold episode. SJP - 002 (naproxen and fexofenadine) reduced symptom severity by two-third, and the duration of the common cold episode approximately by half.
Abstract: The common cold is one of the most frequently experienced immune-related complaints.